Vice President JD Vance referred more than 225 hospitals and healthcare providers to the Department of Justice for alleged insurance fraud tied to youth gender-transition treatments, and warned that those who deliberately cheated the system should face prison time.
Vance announced the move Thursday alongside HHS Secretary Robert F. Kennedy Jr. and Assistant HHS Secretary Brian Christine in a video posted to X. In a separate letter to Attorney General Todd Blanche, Vance transmitted the findings of an HHS report titled "Wolves in White Coats," which outlined what the administration describes as a pattern of fraudulent billing by hospitals that prescribed experimental gender treatments to minors with limited supporting evidence. Just the News first reported on the referral.
The referral asks DOJ to determine whether the providers identified in the report violated federal law, regulations, or policies. No charges have been filed. No arrests have been made. But the language in Vance's letter leaves little ambiguity about where the administration believes the evidence points.
In his letter to Blanche, Vance framed the issue as a financial racket built on vulnerable children.
"Unfortunately, children who express discomfort with their sex have come to be viewed as profit centers by some hospitals and doctors."
He went further, describing the specific mechanism the administration believes providers used to game the insurance system.
"Whether providers miscode treatment in order to secure insurance coverage for gender-transitioning interventions that insurance would not otherwise cover, they should be held accountable. If they have done so intentionally, thereby perpetrating a fraud on Medicaid or on private insurers, they should go to prison."
That last line, "they should go to prison", is not boilerplate. It is a sitting vice president telling the nation's top law enforcement official, in writing, that criminal prosecution is the expected outcome if the facts hold up.
The HHS report gives the referral its teeth. Fox News reported that the "Wolves in White Coats" investigation identified more than $60 million in insurance claims for youth gender-transition treatments billed between 2015 and 2025. About 225 hospitals and health systems across the country had established pediatric gender programs flagged in the report.
The financial incentives are stark. Gender-transition treatments can run up to $75,000 without surgery and nearly $170,000 with surgery, compared to an average healthcare cost of roughly $3,000 for a typical minor. That gap helps explain why, according to the administration's theory, some providers allegedly found it worth the risk to misrepresent what they were billing for.
Vance has made rooting out federal fraud a signature initiative. His anti-fraud task force has already widened enforcement across other sectors, and this referral represents its most politically charged action yet.
Breitbart reported that the HHS findings zeroed in on specific billing practices. Approximately $50 million in puberty blocker claims were billed under a general hormone-disorder code, E34.9, a catch-all diagnostic category, for patients aged nine to seventeen. An additional $11 million was billed under a "precocious puberty" code for patients aged thirteen to seventeen, an age range for which that diagnosis does not apply.
In plain English: providers allegedly told insurers they were treating hormone disorders or early-onset puberty when, according to the report, the actual purpose was gender transition. If true, that is textbook insurance fraud, billing for one thing while delivering another.
This is not the first time a major hospital has faced consequences for similar conduct. Texas Children's Hospital previously settled for $10 million over fraudulent Medicaid billing related to gender-transition procedures. The Centers for Medicare and Medicaid Services has since cut federal Medicaid funding for sex-change procedures on minors.
Vance himself posted on X that the financial structure created perverse incentives. In his words: "It turns out that convincing vulnerable children to reject their gender can create patients for life, earning hospitals tens of thousands of dollars in additional revenue per child."
The vice president's expanding portfolio has drawn attention well beyond fraud enforcement. Staffing changes in his office earlier this year signaled a reshuffling of priorities, and the gender-transition referral suggests his policy footprint continues to grow.
Attorney General Blanche has not publicly acknowledged receipt of the referral or announced any timeline for action. The letter asks DOJ to evaluate whether the providers identified in the HHS report broke federal law. It does not direct prosecution, that authority rests with the Justice Department, but it puts the question squarely on Blanche's desk with the full weight of the vice president's office behind it.
Several questions remain unanswered. The specific hospitals and providers named in the "Wolves in White Coats" report have not been publicly identified. The full contents of the report have not been released. And it is unclear which federal statutes the administration believes were violated, though Medicaid fraud carries serious criminal penalties under existing law.
Vance's letter also called for a broader message. He wrote that rather than allowing "the proliferation of harmful, sex-rejecting procedures on our children," the administration must "send a clear message that any hospitals and providers that have participated in these practices will face justice."
Kennedy and Christine appeared alongside Vance in the announcement video but did not offer public statements of their own, at least not in the reporting available. Their presence, however, signals that HHS is aligned with the vice president's push for criminal accountability, not merely administrative review.
Vance's willingness to take on high-profile fights has defined his tenure. His role inside the West Wing has evolved considerably, and the gender-transition fraud referral may be the clearest test yet of whether his policy ambitions translate into lasting enforcement action.
Fox News traced the timeline back further, noting that Biden-era policies expanded access to gender-transition coverage, creating the insurance framework that providers allegedly exploited. The current administration's position is that those policies, combined with lax oversight, gave hospitals both the financial incentive and the bureaucratic cover to bill aggressively for treatments that many insurers would not have approved under honest coding.
The scale of the alleged fraud, $61 million across a decade, involving hundreds of hospitals, suggests this was not a handful of rogue clinics. If the HHS report's findings hold up under DOJ scrutiny, the picture that emerges is one of a systemic billing practice that exploited ambiguous diagnostic codes to funnel money toward ideologically driven medical interventions on children.
Vance's broader fraud enforcement work has already produced results in other politically charged areas, and the gender-transition referral fits a pattern: follow the money, name the mechanism, and force the legal system to act.
When hospitals allegedly bill taxpayers and insurers tens of millions of dollars for treatments hidden behind fake diagnostic codes, treatments performed on children, the question is not whether someone should investigate. The question is why it took this long.